Akero Therapeutics Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Akero Therapeutics Stock Summary

Akero Therapeutics competes with Terns Pharmaceuticals, Madrigal Pharmaceuticals, Inozyme Pharma, Viking Therapeutics, and Revolution Medicines. Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis company, engages in the development of medicines designed to restore metabolic balance and improve overall health. Akero Therapeutics, Inc. was incorporated in 2017 and is headquartered in South San Francisco, California. Akero Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 37 people.

Akero Therapeutics Key Financial Ratios

Akero Therapeutics Key Balance Sheet Accounts

Akero Therapeutics Key Cash Accounts

Akero Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Akero Therapeutics's current stock value. Our valuation model uses many indicators to compare Akero Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Akero Therapeutics competition to find correlations between indicators driving Akero Therapeutics's intrinsic value. More Info.Akero Therapeutics is rated fifth in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Akero Therapeutics' Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Akero Therapeutics' earnings, one of the primary drivers of an investment's value.

Akero Therapeutics Systematic Risk

Today, most investors in Akero Therapeutics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Akero Therapeutics' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Akero Therapeutics growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Akero Therapeutics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Akero Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Akero Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Akero Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Akero Therapeutics's daily price indicators and compare them against related drivers.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Akero Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. To learn how to invest in Akero Stock, please use our How to Invest in Akero Therapeutics guide.You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Akero Therapeutics. If investors know Akero will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Akero Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Akero Therapeutics is measured differently than its book value, which is the value of Akero that is recorded on the company's balance sheet. Investors also form their own opinion of Akero Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Akero Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Akero Therapeutics' market value can be influenced by many factors that don't directly affect Akero Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Akero Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Akero Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Akero Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.